The store will not work correctly when cookies are disabled.
4-(3,5-Diisopropoxy-phenyl)-6,7-dimethoxy-2-methyl-quinazoline
ID: ALA420999
PubChem CID: 44329702
Max Phase: Preclinical
Molecular Formula: C23H28N2O4
Molecular Weight: 396.49
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cc2nc(C)nc(-c3cc(OC(C)C)cc(OC(C)C)c3)c2cc1OC
Standard InChI: InChI=1S/C23H28N2O4/c1-13(2)28-17-8-16(9-18(10-17)29-14(3)4)23-19-11-21(26-6)22(27-7)12-20(19)24-15(5)25-23/h8-14H,1-7H3
Standard InChI Key: FJTGABKAKGWFTC-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
2.7292 -2.5375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4500 -2.9500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7292 -1.7125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4500 -3.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1625 -2.5292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4417 -1.2917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.0167 -2.9542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0167 -1.3000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1542 -1.7042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3042 -2.5417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3042 -1.7125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7292 -5.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1667 -5.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7292 -4.1792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1625 -4.1792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4500 -5.4167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0167 -5.4167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.8792 -5.4042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.5875 -2.9542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.5917 -1.3042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.8667 -1.2875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8875 -6.2292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3042 -5.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5917 -0.4792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1250 -2.5417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3042 -4.1792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5917 -5.4250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1750 -6.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6042 -6.6417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 2 1 0
5 2 2 0
6 3 1 0
7 1 2 0
8 3 2 0
9 6 2 0
10 7 1 0
11 10 2 0
12 14 1 0
13 15 2 0
14 4 2 0
15 4 1 0
16 13 1 0
17 12 1 0
18 13 1 0
19 10 1 0
20 11 1 0
21 9 1 0
22 18 1 0
23 17 1 0
24 20 1 0
25 19 1 0
26 23 1 0
27 23 1 0
28 22 1 0
29 22 1 0
8 11 1 0
5 9 1 0
12 16 2 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 396.49 | Molecular Weight (Monoisotopic): 396.2049 | AlogP: 5.20 | #Rotatable Bonds: 7 |
Polar Surface Area: 62.70 | Molecular Species: NEUTRAL | HBA: 6 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 3.57 | CX LogP: 4.72 | CX LogD: 4.72 |
Aromatic Rings: 3 | Heavy Atoms: 29 | QED Weighted: 0.55 | Np Likeness Score: -0.65 |
References
1. Charpiot B, Brun J, Donze I, Naef R, Stefani M, Mueller T.. (1998) Quinazolines: combined type 3 and 4 phosphodiesterase inhibitors., 8 (20): [PMID:9873643] [10.1016/s0960-894x(98)00508-3] |